TY - JOUR AU - Bionghi, N. AU - Daftary, A. AU - Maharaj, B. AU - Msibi, Z. AU - Amico, K. R. AU - Friedland, G. AU - Orrell, C. AU - Padayatchi, N. AU - O’Donnell, M. R. PY - 2018 DA - 2018/04/11 TI - Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa JO - BMC Infectious Diseases SP - 171 VL - 18 IS - 1 AB - The introduction of Bedaquiline, the first new antimycobacterial drug in over 40 years, has highlighted the critical importance of medication adherence in drug-resistant tuberculosis (DR-TB) treatment to prevent amplified drug-resistance and derive sustained benefit. Real-time electronic dose monitoring (EDM) accurately measures adherence and allows for titration of adherence support for anti-retroviral therapy (ART). The goal of this study was to evaluate the accuracy and acceptability of a next-generation electronic pillbox (Wisepill RT2000) for Bedaquiline-containing TB regimens. SN - 1471-2334 UR - https://doi.org/10.1186/s12879-018-3080-2 DO - 10.1186/s12879-018-3080-2 ID - Bionghi2018 ER -